Takeshi Hirasawa

ORCID: 0000-0002-6769-4065 · 5 papers in corpus · active 2006-2017

Study types

  • article 4
  • case-report 1

Condition tags

  • endometriosis 2
  • endometrioma 2
article 2017
Alpha-chain of Complement 4-Binding Protein with Fully-Sialylated Glycans (FS-C4BP): Diagnostic utility for early stage ovarian clear cell carcinoma and endometrioma
article 2016
Fully sialylated alpha-chain of complement 4–binding protein: Diagnostic utility for ovarian clear cell carcinoma
·doi:10.1016/j.ygyno.2016.04.092
article 2016
IS-MW-1-3 A novel biomarker that distinguishes early stage ovarian clear cell adenocarcinomas from benign endometriomas(Group 1 Ovarian Cancer,International Session Mini Workshop)
article 2015
Fully-sialylated alpha-chain of complement 4-binding protein: Diagnostic utility for ovarian clear cell carcinoma
Gynecologic oncology ·doi:10.1016/j.ygyno.2015.10.012

OBJECTIVE: While a certain fraction of endometriomas can develop de novo epithelial ovarian cancer (EOC) such as clear cell carcinoma (OCCC), there is currently no useful biomarker available for early detection of OCCC from endometriomas. T…

case-report 2006
Ovarian nongestational choriocarcinoma mixed with various epithelial malignancies in association with endometriosis
Gynecologic oncology ·doi:10.1016/j.ygyno.2006.01.001

BACKGROUND: Ovarian choriocarcinoma (CC) is rarely encountered as compared to uterine CC. Furthermore, ovarian CC coexisting with surface epithelial tumor is very rare. CASE: A 50-year-old postmenopausal woman, gravida 0, was admitted to o…